Literature DB >> 15336813

Left ventricular hypertrabeculation/noncompaction with and without neuromuscular disorders.

Claudia Stöllberger1, Maria Winkler-Dworak, Gerhard Blazek, Josef Finsterer.   

Abstract

BACKGROUND: Left ventricular hypertrabeculation/noncompaction (LVHT) is frequently associated with neuromuscular disorders (NMD). It is unknown, whether LVHT patients differ according to the presence or absence of NMD. Aim of the study was to assess, if clinical, ECG or echocardiographic findings differ between LVHT patients with and without NMD.
METHODS: Included were all patients, in whom LVHT was diagnosed between June 1995 and February 2003 in one echocardiographic laboratory. All patients underwent a cardiologic examination and were invited for a neurologic investigation.
RESULTS: Of 77 patients with LVHT (19 female, mean age 52 years), 59 were investigated neurologically. Eleven were neurologically normal, 21 had a definite NMD (metabolic myopathy, n=15; Leber's hereditary optic neuropathy, n=3; myotonic dystrophy, n=2 and Becker muscular dystrophy, n=1). The remaining 27 had a NMD of unknown etiology. Neurologically normal patients had more often anginal chest pain than patients with definite NMD (64% vs. 14%, P=0.0042) or NMD of unknown etiology (64% vs. 26%, P=0.0157). Neurologically normal patients were more often in NYHA class 0 or I than patients with NMD of unknown etiology (64% vs. 26%, P=0.0289) and had a thinner interventricular septum than patients with NMD (10.6 mm vs. 12.8 mm, P=0.0253).
CONCLUSIONS: Cardiac abnormalities are hardly different between patients with and without NMD. Copyright 2003 Elsevier Ireland Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 15336813     DOI: 10.1016/j.ijcard.2003.08.014

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

1.  Implications of genetic testing in noncompaction/hypertrabeculation.

Authors:  Joseph T C Shieh
Journal:  Am J Med Genet C Semin Med Genet       Date:  2013-07-10       Impact factor: 3.908

2.  Progressive left ventricular noncompaction and systolic dysfunction.

Authors:  Irene M Hutchins; Saul Schaefer
Journal:  Exp Clin Cardiol       Date:  2012

3.  Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction.

Authors:  C Lofiego; E Biagini; F Pasquale; M Ferlito; G Rocchi; E Perugini; L Bacchi-Reggiani; G Boriani; O Leone; K Caliskan; F J ten Cate; F M Picchio; A Branzi; C Rapezzi
Journal:  Heart       Date:  2006-04-27       Impact factor: 5.994

Review 4.  Left ventricular non-compaction and its cardiac and neurologic implications.

Authors:  Josef Finsterer
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

5.  Diagnosing left ventricular noncompaction by echocardiography and cardiac magnetic resonance imaging and its dependency on neuromuscular disorders.

Authors:  Claudia Stöllberger; Wolfgang Kopsa; Robert Tscherney; Josef Finsterer
Journal:  Clin Cardiol       Date:  2008-08       Impact factor: 2.882

Review 6.  The role of α-dystrobrevin in striated muscle.

Authors:  Masayuki Nakamori; Masanori P Takahashi
Journal:  Int J Mol Sci       Date:  2011-03-04       Impact factor: 5.923

7.  Anesthetic experience of patient with isolated left ventricular noncompaction: a case report.

Authors:  Doyeon Kim; Eunhee Kim; Jong-Hwan Lee; Chung Su Kim; Sangmin Maria Lee; Jung Eun Lee
Journal:  Korean J Anesthesiol       Date:  2016-06-01

8.  NT-pro-BNP in patients with left ventricular hypertrabeculation/non-compaction.

Authors:  Katharina Rapatz; Josef Finsterer; Astrid Voill-Glaninger; Nastasia Wilfinger-Lutz; Maria Winkler-Dworak; Claudia Stöllberger
Journal:  ESC Heart Fail       Date:  2020-09-23

9.  A Rare Case of Left Ventricular Non-Compaction with Coronary Artery Anomaly Complicated by ST-Elevation Myocardial Infarction and Subcutaneous Defibrillator Implantation.

Authors:  Francesca Romana Prandi; Federica Illuminato; Chiara Galluccio; Marialucia Milite; Massimiliano Macrini; Alessio Di Landro; Gaetano Idone; Marcello Chiocchi; Francesco Paolo Sbordone; Domenico Sergi; Francesco Romeo; Francesco Barillà
Journal:  Int J Environ Res Public Health       Date:  2022-01-11       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.